ENBUMYST
Live / Applied — Response to non-final action entered (as of 06 Mar 2026)
What this means for you
Not registered yet, but its 21 Sept 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99404639
- Mark type
- Design + words
- Filed
- 21 Sept 2025
- Attorney of record
- Michael James Sweetman
Goods and services
- Class 005 — Pharmaceuticals: Cardiovascular agents for medical purposes; Cardiovascular pharmaceutical preparations; Cardiovascular treatment preparations; Cardiovascular pharmaceuticals; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Medical apparatus and instruments in the nature of nasal sprays for use in delivering cardiovascular pharmaceuticals via nasal spray procedures; Medical apparatus and instruments in the nature of nasal sprays for treating cardiovascular disease
- Class 010 — Medical apparatus: Medical apparatus and instruments in the nature of a delivery device for nasal spray for use in delivering cardiovascular pharmaceuticals via nasal spray procedures
Owner
- Corstasis Therapeutics, Inc., Henderson, NV, US
Prosecution history
- 06 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 26 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Feb 2026 — NON-FINAL ACTION E-MAILED
- 26 Feb 2026 — NON-FINAL ACTION WRITTEN
- 13 Feb 2026 — ASSIGNED TO EXAMINER
- 12 Feb 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 12 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 21 Sept 2025 — APPLICATION FILING RECEIPT MAILED
- 21 Sept 2025 — NEW APPLICATION ENTERED